ADIPOQ and obesity due to melanocortin 4 receptor deficiency: The mechanism of the anti-obesity effect of NAOs was confirmed in several preclinical studies, including weight loss, adipocyte size reduction, blood glucose and lipid improvement through PPAR-r and MAPK signaling pathways, adiponectin regulation, and gut microbiome modulation [13–15, 17].